News

Cancer Research UK’s Centre for Drug Development (CDD) will sponsor and fund a Phase Ia and Phase Ib clinical trial for a drug called BT1718, a Bicycle Drug

The deal covers the on-demand supply and distribution of BioQ Pharma’s pre-filled Ropivacaine Readyfusor for post-operative pain management in Europe, excluding France and Germany. Under the terms of

Headquartered in Ahmedabad, India, Claris Injectables has a portfolio of essential generic injectable medicines like anesthesia and analgesics, renal, anti-infectives and critical care in a range of presentations

The compound was well-tolerated, with negligible incidences of nausea and vomiting across all arms of the study. Trends towards weight loss were also observed. “It is remarkable to

The patent details methods used to develop sofosbuvir-based medicines for the treatment of patients with hepatitis C virus (HCV) infection, including Sovaldi and Harvoni. The jury’s verdict upholds patent

The deal includes refinancing of existing Capsugel debt of about $2bn. KKR acquired Capsugel from Pfizer for $2.4bn in 2011. Based in Morristown, New Jersey, Capsugel is engaged

VistaGen licensed exclusive rights of the cardiac stem cell technologies from University Health Network (UHN), Canada's largest research hospital, pursuant to a strategic research agreement with UHN and

Goldfinch was launched with $55m in Series A financing to translate breakthroughs in genetics and kidney biology to lead a new era of therapeutic development targeting the molecular

Ocaliva is a potent and selective agonist of the farnesoid X receptor (FXR), which is expressed at high levels in the liver and intestine and thought to be